{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Rocky Mount",
      "state": "NC",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA008845"
        ],
        "brand_name": [
          "QUELICIN"
        ],
        "generic_name": [
          "SUCCINYLCHOLINE CHLORIDE"
        ],
        "manufacturer_name": [
          "Hospira, Inc."
        ],
        "product_ndc": [
          "0409-6629",
          "0409-6970"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAMUSCULAR",
          "INTRAVENOUS"
        ],
        "substance_name": [
          "SUCCINYLCHOLINE CHLORIDE"
        ],
        "rxcui": [
          "1594585",
          "1594587",
          "1594589",
          "1594593"
        ],
        "spl_id": [
          "85a1ebc8-a6d3-4c1c-8ea1-a1d159f08dd7"
        ],
        "spl_set_id": [
          "fb08161e-7711-406d-e7b3-ea4515c07983"
        ],
        "package_ndc": [
          "0409-6629-12",
          "0409-6629-02",
          "0409-6970-10",
          "0409-6629-25"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "I9L0DDD30I"
        ]
      },
      "product_type": "Drugs",
      "event_id": "77533",
      "recalling_firm": "Hospira a Pfizer Company",
      "address_1": "4285 N Wesleyan Blvd",
      "address_2": "N/A",
      "postal_code": "27804-8612",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore",
      "recall_number": "D-1048-2017",
      "product_description": "Succinylcholine Chloride Injection, USP 200 mg (20 mg/mL) Quelicin Multiple-dose vial, 10 mL,  For I.V. or I.M. use.  a.) one vial (NDC: 0409-6629-02), b.) 25 vial carton (NDC: 0409-6629-25).",
      "product_quantity": "15,034,600 10 mL multiple dose use vials",
      "reason_for_recall": "Lack of Sterility Assurance",
      "recall_initiation_date": "20170615",
      "center_classification_date": "20170801",
      "termination_date": "20200720",
      "report_date": "20170809",
      "code_info": "a.) one vial    Lot: 74393EV Exp. 05/01/2018  Lot: 75157EV Exp. 06/01/2018  Lot: 75367EV, Exp. 06/01/2018    b.) 25 vial carton    Lot: 75158EV; Exp. 06/01/2018"
    }
  ]
}